Clinical Trial Update: Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating rosiglitazone for prevention of coronary artery disease in patients with impaired glucose tolerance; sponsor listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Impaired Glucose Tolerance

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Denver Research Institute | Conditions: Impaired Glucose Tolerance | Phase 4 | Status: UNKNOWN